Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 15

    1.

    Drug-drug interaction in a kidney transplant recipient receiving HIV salvage therapy and tacrolimus.

    Mertz D, Battegay M, Marzolini C, Mayr M.

    Am J Kidney Dis. 2009 Jul;54(1):e1-4. Epub 2009 Apr 5.PMID: 19346040 [PubMed - indexed for MEDLINE]Related articles

    2.

    Transporter-mediated protection against thiopurine-induced hematopoietic toxicity.

    Krishnamurthy P, Schwab M, Takenaka K, Nachagari D, Morgan J, Leslie M, Du W, Boyd K, Cheok M, Nakauchi H, Marzolini C, Kim RB, Poonkuzhali B, Schuetz E, Evans W, Relling M, Schuetz JD.

    Cancer Res. 2008 Jul 1;68(13):4983-9.PMID: 18593894 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression.

    Marzolini C, Tirona RG, Gervasini G, Poonkuzhali B, Assem M, Lee W, Leake BF, Schuetz JD, Schuetz EG, Kim RB.

    Mol Endocrinol. 2007 Aug;21(8):1769-80. Epub 2007 May 22.PMID: 17519356 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.

    Ribaudo HJ, Haas DW, Tierney C, Kim RB, Wilkinson GR, Gulick RM, Clifford DB, Marzolini C, Fletcher CV, Tashima KT, Kuritzkes DR, Acosta EP; Adult AIDS Clinical Trials Group Study.

    Clin Infect Dis. 2006 Feb 1;42(3):401-7. Epub 2005 Dec 27.PMID: 16392089 [PubMed - indexed for MEDLINE]Related articles

    5.

    Placental transfer of antiretroviral drugs.

    Marzolini C, Kim RB.

    Clin Pharmacol Ther. 2005 Aug;78(2):118-22. No abstract available. PMID: 16084846 [PubMed - indexed for MEDLINE]Related articles

    6.

    Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients.

    Fellay J, Marzolini C, Decosterd L, Golay KP, Baumann P, Buclin T, Telenti A, Eap CB.

    Eur J Clin Pharmacol. 2005 Feb;60(12):865-73. Epub 2005 Jan 19.PMID: 15657782 [PubMed - indexed for MEDLINE]Related articles

    7.

    Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

    Haas DW, Ribaudo HJ, Kim RB, Tierney C, Wilkinson GR, Gulick RM, Clifford DB, Hulgan T, Marzolini C, Acosta EP.

    AIDS. 2004 Dec 3;18(18):2391-400.PMID: 15622315 [PubMed - indexed for MEDLINE]Related articles

    8.

    Population pharmacokinetics of indinavir in patients infected with human immunodeficiency virus.

    Csajka C, Marzolini C, Fattinger K, Décosterd LA, Telenti A, Biollaz J, Buclin T.

    Antimicrob Agents Chemother. 2004 Sep;48(9):3226-32.PMID: 15328077 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pharmacogenomics of the OATP and OAT families.

    Marzolini C, Tirona RG, Kim RB.

    Pharmacogenomics. 2004 Apr;5(3):273-82. Review.PMID: 15102542 [PubMed - indexed for MEDLINE]Related articles

    10.

    MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment.

    Bleiber G, May M, Suarez C, Martinez R, Marzolini C, Egger M, Telenti A; Swiss HIV Cohort Study.

    J Infect Dis. 2004 Feb 15;189(4):583-6. Epub 2004 Jan 29.PMID: 14767809 [PubMed - indexed for MEDLINE]Related articles

    11.

    Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.

    Marzolini C, Paus E, Buclin T, Kim RB.

    Clin Pharmacol Ther. 2004 Jan;75(1):13-33. Review.PMID: 14749689 [PubMed - indexed for MEDLINE]Related articles

    12.

    Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection.

    Csajka C, Marzolini C, Fattinger K, Décosterd LA, Fellay J, Telenti A, Biollaz J, Buclin T.

    Clin Pharmacol Ther. 2003 Jan;73(1):20-30.PMID: 12545140 [PubMed - indexed for MEDLINE]Related articles

    13.

    Efficacy and safety of fluvastatin in hyperlipidemic protease inhibitor-treated HIV-infected patients.

    Doser N, Kübli S, Telenti A, Marzolini C, Chave JP, Feihl F, Buclin T, Pannatier A, Darioli R, Nicod P, Waeber B, Mooser V.

    AIDS. 2002 Sep 27;16(14):1982-3. No abstract available. PMID: 12351967 [PubMed - indexed for MEDLINE]Related articles

    14.

    Transplacental passage of protease inhibitors at delivery.

    Marzolini C, Rudin C, Decosterd LA, Telenti A, Schreyer A, Biollaz J, Buclin T; Swiss Mother + Child HIV Cohort Study.

    AIDS. 2002 Apr 12;16(6):889-93.PMID: 11919490 [PubMed - indexed for MEDLINE]Related articles

    15.

    Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

    Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave JP, Decosterd LA, Furrer H, Opravil M, Pantaleo G, Retelska D, Ruiz L, Schinkel AH, Vernazza P, Eap CB, Telenti A; Swiss HIV Cohort Study.

    Lancet. 2002 Jan 5;359(9300):30-6.PMID: 11809184 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...